ArticleJournal of experimental & clinical cancer research : CR2016

MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1).

Lin Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.